関連する実験動画
Updated: May 6, 2026
12:12
Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes
Published on: June 16, 2011
12.9K
自己免疫性糖尿病におけるFasの役割
A V Chervonsky1, Y Wang, F S Wong
1Section of Immunobiology, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
Cell
|April 4, 1997
まとめ
ファスリンガンド (FasL) 発現は通常,免疫部位を保護する. しかし,自己免疫性糖尿病では,FasL変異遺伝子マウスはベータ細胞破壊の増加を示し,Fas誘発の自己破壊が糖尿病の主要なメカニズムであることを明らかにしました.
科学分野:
- 免疫学 免疫学とは
- エンドクリノロジー エンドクリノロジー
- 分子生物学は分子生物学である.
背景:
- 免疫学的に優位な部位は,T細胞媒介による攻撃を防ぐためにFasリンガンド (FasL) を利用する.
- 活性化されたT細胞はFasを発現し,FasLの相互作用によってアポトーシスを引き起こします.
- 自己免疫糖尿病は,T細胞が臓のβ細胞を破壊することを含む.
研究 の 目的:
- 非肥満糖尿病 (NOD) のマウスのベータ細胞を自己免疫破壊から保護するFasLの役割を調査する.
- ベータ細胞におけるFasL発現を設計することで,自己免疫糖尿病を予防できるかどうかを判断する.
主な方法:
- ベータ細胞特異のプロモーターを用いたFasLトランスジェニックNODマウスの生成.
- トランスジェニックおよびファス陰性NODマウスにおけるT細胞媒介によるβ細胞破壊の評価.
- 糖尿病性T細胞への反応としてβ細胞におけるFas発現の分析.糖尿病性T細胞に対する反応としてβ細胞におけるFas発現の分析.
主要な成果:
- ベータ細胞でFasLを発現するトランスジェニックNODマウスは,糖尿病性T細胞に対する感受性が高かった.
- ベータ細胞の自己破壊は,T細胞媒介によるFas誘導で観察された.
- ファス陰性NOD (lpr/lpr) のマウスは,自己免疫糖尿病に抵抗性がありました.
結論:
- 臓のβ細胞にFas発現を誘導することは,自己免疫糖尿病における重要な病原性メカニズムである.
- ベータ細胞のFas媒介によるアポプトシスは,T細胞を直接殺すのではなく,糖尿病の発症を誘発する.
- Fas誘発のアポプトーシスをターゲットにすることは,自己免疫糖尿病の新たな治療戦略を提供する可能性があります.
関連する概念動画
01:20Pathophysiology of Diabetes
3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
01:26Diabetes Mellitus: Introduction
57
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
57
01:12Type I Diabetes I: Introduction
89
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
89
01:26Type I Diabetes II: Pathophysiology
122
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
122
01:26Type II Diabetes I: Introduction
57
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
57
01:24Type II Diabetes II: Pathophysiology
45
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
45